William Chalmers

William Chalmers

ID: 1b83995a-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

No leave required for experimental testing conducted prior to litigation

Pharma in Brief · April 22, 2020

Ontario implements regulatory changes to streamline drug formulary listing and reduce government payments to pharmacies

Pharma in Brief · December 19, 2019

Ontario reduces restrictions on ordinary commercial term benefits and private label products

Pharma in Brief · December 17, 2019

Ontario consults on changes to streamline drug formulary listing and reduce government payments to pharmacies

Pharma in Brief · November 10, 2019

Stockpiling generic manufacturers may be liable for direct infringement of “composition for a use” claims

Pharma in Brief · November 7, 2019

Practice Areas

Health Care and Life Sciences

Jurisdictions